Evolution of drug regulations and regulatory innovation for anticancer drugs in China

• Main Authors: Yang Liu (Author), Ning Zhang (Author), Cuicui Xie (Author), Yale Jiang (Author), Yunhe Qin (Author), Liyun Zhou (Author), Yi Fan (Author), Lianjie Ren (Author), Chen Yin (Author), Huan Yang (Author), Wei Xie (Author), Qing Zhai (Author), Guanqiao Li (Author), Hongzhuan Chen (Author), Xiaoyuan Chen (Author)
• Formato: Livro
• Publicado em: Elsevier, 2022-12-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Over the past two decades, China has introduced significant changes to drug regulations through regulatory innovations to accelerate drug review and approvals, keeping in line with the rapidly growing scientific innovation in drug research and development (R&D). In this study, we outlined the re...